Copley to launch new breath simulator for inhaler testing
Copley Scientific says new ‘breath simulator’ will let developers predict real world DPI and MDI performance more accurately.
Archives for April 22, 2012
Cetero warns of “fatal” funding alternatives in defence of sale
Cetero has hit back at critics of its financing plan by saying use of third-party funders would cause a “likely fatal” fight.
Albemarle operating profit up 23% on positive pharma trends
Albemarle posted surging fine chemistry operating profits as a result of positive pharma trends and other tailwinds.
Raw material woes for Pakistan could lead to swift exit for drugsmakers, says ABC
The American Business Council (ABC) has warned US drugsmakers working in Pakistan to brace themselves for supply chain disruptions as the Government imposes heavy delays on the process used to allocate raw materials to manufacturers.
Surya gets EDQM CEP and TEVA OK as it tries to tackle debts
Indian contract manufacturer Surya Pharmaceutical has received an EDQM Certificate of Suitability (CEP) for an antibiotic API and approval for its Banur plant from Teva.
Warnex repays debentures, signs financing deal and lists on new exchange
Battling contract services firm Warnex has repaid debentures through a new financing deal and will list on the Toronto Stock Exchange’s venture exchange from tomorrow.
Analysts predict Covance cuts to align tox capacity with demand
Analysts expect Covance to cut toxicology capacity in response to continued weak demand for GLP services.
SFDA clamps down on chromium-tainted gel capsules
The SFDA has closed down 10 gel capsule factories and revoked two licenses after finding 23 batches of products tainted with “excessive levels” of the toxic metal chromium.
Kemwell adds cGMP pilot plant to expand capabilities in India
Kemwell Biopharma has added a 7,500 sq ft cGMP pilot plant to complement its commercial-scale production facility in Bangalore, India.